Berberis aristata (Indian barberry) plant growing in rocky Himalayan terrain, showing thorny woody stems and clusters of bright yellow flowers.

Berberine and Heart–Metabolic Wellness: A Science-Based Overview

Truth Full Health

What Is Berberine?

Berberine is a naturally occurring compound found in several plants, including Berberis aristata (Indian barberry), Berberis vulgaris (European barberry) and other barberry species (Table 1).

It has been part of traditional wellness practices in regions such as India, China, Europe, and North America, with records dating back thousands of years for general vitality.

 

How It Works in the Body

Berberine has been studied across several health-related areas; one area of interest is heart and metabolic wellness (lipids, glucose, and blood-pressure markers).   

Modern research suggests berberine influences metabolism through several mechanisms, most notably the activation of AMP-activated protein kinase (AMPK)—a cellular “energy switch.”[1]

AMPK activation may support healthy mitochondrial function, help the body use glucose more efficiently, and shift energy usage toward fat metabolism.

Other pathways have also been identified, such as supporting nitric oxide production in blood vessels and modulating certain enzymes related to lipid metabolism (Table 2).

Table 1. Common plants containing berberine

Plant Name (Latin) Common Name Typical Region Part Used for Berberine Traditional Use
(non-disease, general wellness)
Berberis aristata Indian barberry India, Nepal, Bhutan Root, stem bark Used in Ayurveda/Himalayan traditions to support digestive & metabolic wellness
Berberis vulgaris European barberry Europe, N. Africa, W. Asia Root bark, stem bark Traditional European folk tonic for general wellness & vitality
Mahonia aquifolium (syn. Berberis aquifolium) Oregon grape Western North America Root, root bark North American herbalism to promote skin & digestive balance
Coptis chinensis Chinese goldthread China Rhizome Used in Chinese traditions to support overall wellness & digestive harmony
Hydrastis canadensis Goldenseal Eastern North America Root, rhizome North American traditions for digestive & immune system support
Phellodendron amurense Amur cork tree China, Korea, Japan, Far East Russia Bark Used in Chinese traditions to support healthy liver function & metabolic balance
Tinospora cordifolia Heart-leaved moonseed India, Sri Lanka, Myanmar Stem Ayurveda traditions for vitality and immune wellness

Note: While all of these plants contain berberine (typically ranging from less than 1% to a few percent), the amount can vary by species, plant part, and harvest conditions. Supplements containing berberine typically use standardized extracts to ensure consistent berberine content.

 

Table 2. How berberine may support various heart and metabolic health areas

Health Area Effect AMPK Dependency
Blood Lipids Helps maintain healthy cholesterol balance by reducing activities of natural cholesterol production enzymes (HMG-CoA reductase) AMPK-dependent
Blood Lipids Supports LDL (“bad” cholesterol) clearance by increasing LDL receptor activity Partially AMPK-dependent
Blood Lipids Encourages the body to burn fats for energy (fatty acid oxidation) AMPK-dependent
Blood Sugar Supports glucose uptake in muscle via increased GLUT4 transporter movement Partially AMPK-dependent
Blood Sugar Helps maintain normal blood sugar by moderating the liver’s glucose output (gluconeogenesis) AMPK-dependent
Blood Sugar Slows carbohydrate breakdown in the gut by inhibiting enzymes such as α-glucosidase AMPK-independent
Blood Pressure Supports healthy circulation by encouraging nitric oxide (NO) production in blood vessels Partially AMPK-dependent
Blood Pressure Helps protect blood vessels by reducing oxidative stress and inflammation AMPK-independent
Blood Pressure Indirect support through beneficial effects on lipid and glucose balance Partially AMPK-dependent

 

What Does the Human Research Show?

Berberine has a long history of traditional use, and modern laboratory studies have explored its effects at the cellular level.

This combination of tradition and early scientific work offers some reassurance for consumers like us.

However, there’s an important consideration: it can be challenging to determine the most appropriate daily amount and duration of use—and the likely health support—without well-designed, human studies.

For supplements, the most reliable evidence comes from randomized controlled trials (RCTs) that compare berberine with a placebo or other supplement ingredient(s), measuring health-related outcomes in people.

Why focus on human RCTs?

They help reduce the uncertainty that can put either our health or our money at risk, especially when it comes to identifying the right dose and length of time that may support wellness goals.

We’ll explore the details of why these matters in another article.

Different RCTs may produce varying or even conflicting results.

When enough well-designed RCTs are available, researchers can combine their findings using a method called meta-analysis.

This approach looks at the total body of evidence, which can give a more reliable picture of whether a supplement ingredient may help support specific aspects of health.

Our comprehensive review of the scientific literature conducted across 2024 to early 2025 identified at least*:

  • Seven meta-analyses of RCTs involving berberine in support of healthy blood lipid levels
  • Two meta-analyses of RCTs involving berberine in support of healthy blood sugar levels, and
  • One meta-analysis of RCTs involving berberine in support of healthy blood pressure levels (Table 3).

*Although unlikely, we may have accidentally overlooked some studies, or new ones may have been published after our search period. Here, I focus on sharing and discussing findings from meta-analyses rather than individual RCTs, because meta-analyses combine and summarize the results of multiple RCTs into one overall assessment.

 

Table 3: Meta-analyses of Berberine in Heart and Metabolic Health

Health Area Study Reference Number of Human RCTs Included* Do the Findings Combined Across RCTs Suggest That Berberine May Help Support Healthy Blood Lipid Levels?**
Blood lipids

Title: The Effects of Berberine on Blood Lipids: A Systemic Review and Meta-Analysis of Randomized Controlled Trials.

First author: H. Dong.

Journal: Planta Medica.

Year of publication: 2013.

11 Yes
Blood lipids

Title: Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia, and hypertension.

First author: J. Lan.

Journal: Journal of Ethnopharmacology.

Year of publication: 2015.

27 Yes
Blood lipids

Title: Efficacy and safety of berberine for dyslipidaemias: A systematic review and meta-analysis of randomized clinical trials.

First author: J. Ju.

Journal: Phytomedicine.

Year of publication: 2018.

16 Yes
Blood lipids

Title: Efficacy and safety of berberine alone or combined with statins for the treatment of hyperlipidemia.

First author: L. S. Zhang.

Journal: The American Journal of Chinese Medicine.

Year of publication: 2019.

11 Yes
Blood lipids

Title: The effect of berberine on metabolic profiles in type 2 diabetic patients: a systematic review and meta-analysis of randomized controlled trials.

First author: J. Guo.

Journal: Oxidative Medicine and Cellular Longevity.

Year of publication: 2021.

46 Yes
Blood lipids

Title: Overall and sex-specific effect of berberine for the treatment of dyslipidemia in adults: a systematic review and meta-analysis of randomized placebo-controlled trials.

First author: J. E. Blais.

Journal: Drugs.

Year of publication: 2023.

18 Yes
Blood lipids

Title: Efficacy and safety of berberine for several cardiovascular diseases: a systematic review and meta-analysis of randomized controlled trials.

First author: L. Yang.

Journal: Phytomedicine.

Year of publication: 2023.

44 Yes
Blood sugar

Title: Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia, and hypertension.

First author: J. Lan.

Journal: Journal of Ethnopharmacology.

Year of publication: 2015.

27 Yes
Blood sugar

Title: The effect of berberine on metabolic profiles in type 2 diabetic patients: a systematic review and meta-analysis of randomized controlled trials.

First author: J. Guo.

Journal: Oxidative Medicine and Cellular Longevity.

Year of publication: 2021.

46 Yes
Blood pressure

Title: Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia, and hypertension.

First author: J. Lan.

Journal: Journal of Ethnopharmacology.

Year of publication: 2015.

27 Yes

*There may be individual RCTs that overlap across the meta-analyses

**In the studies summarized, results showed a statistically significant difference between berberine and the comparator group for at least one outcome measured in the review. This does not mean that all individuals will experience the same effect.

 

As shown above, there is a substantial number of published human RCTs that have examined berberine’s potential to help maintain healthy levels of blood lipids, blood sugar, and blood pressure.

In these studies, berberine was generally well tolerated in the short term when taken at the studied dosages.

That said, it’s important not to assume that all supplements are safe for everyone.

Before starting any supplement, it’s wise to:

  • Talk with a qualified healthcare provider
  • Check with the supplement manufacturer about safety information
  • Look for scientific evidence or clinical guidelines from reputable sources

This helps reduce the chance of avoidable risks and ensures your supplement choices are made with your health in mind.

 

Nuances in the Published Berberine Human Research

The amount of human-based research on berberine is not across all heart and metabolic health areas.

The strongest body of evidence is for blood lipids, followed by blood sugar and then blood pressure.

When there are fewer studies, there is more uncertainty about how reliably berberine may help maintain healthy levels in that area.

For example, a 2015 meta-analysis (listed in Table 3) found that berberine appeared to support healthy blood pressure in people already taking prescribed blood pressure medications.

However, the evidence for berberine’s role in maintaining healthy blood pressure in those not on such medications is less certain.

On the positive side, the fact that there is enough human RCT evidence to conduct multiple meta-analyses means berberine is comparatively well studied among supplement ingredients.

Many other ingredients do not have this level of human research.

 

1. Interpreting the strength of the evidence

Even though the largest number of berberine studies focus on blood lipids, this does not guarantee that berberine is the most effective supplement ingredient for that purpose.

What this research does provide is greater confidence in what we might expect from berberine compared to ingredients with less evidence.

As consumers, it’s worth comparing berberine’s research findings to those for other supplement ingredients aimed at the same health area.

While results from berberine studies are promising, individual responses can vary depending on factors such as diet, lifestyle, and overall health status.

 

2. Who Was Studied and How It Applies to You

Most individual RCTs on berberine have been conducted in Chinese (Asian) population.

In the medical community, it is well recognized that the relationship between supplement use and how our bodies may respond may differ across regions or racial/ethnic groups.[2],[3],[4]

This can be due to differences in lifestyle, healthcare practices, and genetic factors.

Because of this, it’s best to have research covering diverse populations to ensure results apply more broadly.

Some berberine studies have included participants from different regions and backgrounds, and we considered those in our review.

 

3. Evidence-based daily amount

In the supplement field, recommended daily amounts are often based on published scientific research.

Healthcare providers commonly reference these studies when advising on supplement use, rather than creating amounts entirely independent of the available evidence.

Based on our comprehensive review of published human research, the evidence-supported daily intake range for berberine (in the form of berberine HCl) that has been studied for maintaining healthy blood lipid, blood sugar, and blood pressure levels across various populations is approximately 900 to 1500 mg per day.*

This range may change as new evidence becomes available.

We present a range rather than a single “ideal” dose to reflect differences among individuals and the variation in doses used in published studies.

While a single fixed dose may appear more convenient to consumers like us, it may not always align with the diversity of research findings, and might not reflect all the potential effects seen in studies.

* This information is provided for educational purposes only and is not a personal dosage recommendation.

 

Berberine vs. Berberine HCl (Label-Reading Tip)

In most scientific studies, the form of berberine used is berberine hydrochloride (berberine HCl).

This is a salt form of berberine, and it’s what you will usually see listed in the “Supplement Facts” panel on a product label.

The key difference is that berberine HCl is about 90% actual berberine by weight.

That means:

  • 300 mg berberine HCl contains about 271.5 mg berberine
  • 300 mg berberine (pure) corresponds to about 331.5 mg berberine HCl

When comparing your supplement’s label to research dosages, make sure you know whether the number shown is for berberine HCl or for pure berberine.

If you’re unsure, check with your healthcare provider or the supplement manufacturer for clarification.

 

“Enhanced-bioavailability” Versions: Promise vs. Proof

Some newer supplement products use novel formulations of berberine that aim to improve absorption in the body.

Two helpful review articles that summarize these developments are:

  • Title: Bioavailability of berberine: challenges and solutions. First author: A. Thomas. Journal: İstanbul Journal of Pharmacy. Year of publication: 2021.
  • Title: Research progress on pharmacological effects and bioavailability of berberine. First author: Y. Cui. Journal: Naunyn-Schmiedeberg's Archives of Pharmacology (Springer). Year of publication: 2024.

 

Examples of novel formulations

The study published by Thomas (2021) describes several innovative delivery methods—such as liposomes, micelles, and microemulsions.

Some of these (like chitosan-coated nano-liposomes) have shown improved bioavailability in in vitro studies—that is, experiments done outside a living organism, in lab equipment such as test tubes or petri dishes.[5]

Other forms, like dihydroberberine, have been studied in human RCTs to measure absorption, but those studies did not assess whether the formulation supported healthy blood lipid, blood sugar, or blood pressure levels.[6]

Some formulations have early human evidence. For example:

  • Berberine Phytosome has been studied in an RCT and showed potential support for healthy blood sugar in people who were overweight.[7]
  • On the other hand, there are recent reports where certain formulations did not show measurable support for heart and metabolic health outcomes[8]—although more data is needed to confirm the lack of benefit.

 

Key questions for consumers

These newer formulations may sound promising — but before deciding whether they’re right for us as consumers, it’s worth pausing to consider a few key questions.

Using the spectrum thinking approach we discussed in another article, here are some to ask.

  1. These formulations claims improved bioavailability—5x, 10x, or even 100x higher. That’s great. How should that translate into dosage compared to traditional berberine?
  2. Are there studies that directly test and confirm that conversion?
  3. Is the conversion supported by independent healthcare experts outside of those connected to the supplement industry?
  4. Has the novel form been studied in one or more human RCTs showing it may support healthy blood lipid, blood sugar, or blood pressure levels? If so, at what daily dose?
  5. How much total scientific literature exists for the traditional form versus the novel form?
  6. Is there published safety data for the novel form?

 

My current perspective on the evidence

Right now, traditional berberine (especially berberine HCl) has far more supporting research—multiple meta-analyses and many human RCTs—across different health areas.

Does this mean the novel formulations don’t work?

Absolutely not!

It simply means their evidence base is much smaller, and we may still be some way from knowing the optimal dosage for heart and metabolic health support.

For example, while it’s encouraging that Berberine Phytosome has preliminary research supporting healthy blood sugar levels, I would like to see:

  • Studies in a wider variety of people
  • Evidence on additional health areas, such as blood lipids and blood pressure
  • Direct comparisons with traditional berberine
  • More published safety data

Developing these kinds of studies is costly, but important for confirming the real-world value of these newer formulations.

With more investment into supplement research, consumers could have stronger, more reliable information to guide their choices.

 

Final words

Berberine has been used by humans for centuries, and in recent years, a growing body of scientific research has explored its potential role in supporting heart and metabolic health.

As we have seen, the amount and strength of evidence for berberine’s role in supporting healthy blood lipids, blood sugar, and blood pressure are not equal—some areas have more research than others.

For those interested in maintaining healthy levels in these areas, it may be worth exploring supplement options that include berberine along with other ingredients that have also been studied for similar purposes.

As consumers, staying informed helps us make thoughtful choices.

Let’s continue learning, asking questions, and making decisions that best fit our individual health needs.

I’m here to help—wishing us all the best on our health journeys!

 

Sincerely,

Derek Tang, PhD, MS, BSPharm

Truth Full Health

Your Trusted Supplement Partner

 

Disclaimer: All blogged content is for informational purposes only and does not replace professional medical advice. Statements made about vitamins or supplements (officially called “dietary supplements”) have not been evaluated by the U.S. Food and Drug Administration (FDA). Dietary supplements are not intended to diagnose, treat, cure, or prevent any disease. Always consult with a qualified healthcare provider before beginning any new supplement, diet, or lifestyle program. To comply with FDA and FTC requirements, we summarize published research for general educational purposes only and do not make disease-treatment claims or unsubstantiated statements about any product. We encourage readers to review the cited studies and to contact us with general questions; we cannot provide individualized medical advice.

 

[1] Title: Berberine improves lipid dysregulation in obesity by controlling central and peripheral AMPK activity. First author: W. S. Kim. Journal: American Journal of Physiology – Endocrinology and Metabolism. Year of publication: 2009.

[2] Title: Effect of vitamin D supplementation on free and total vitamin D: A comparison of Asians and Caucasians. First author: J.S. Gopal-Kothandapani. Journal: Clinical Endocrinology (Oxford).
Year of publication: 2019.

[3] Title: Contribution of Dietary Supplements to Nutritional Adequacy in Race/Ethnic Population Subgroups in the United States. First author: J.B. Blumberg. Journal: Nutrients. Year of publication: 2017.

[4] Title: Racial differences in calculated bioavailable vitamin D with vitamin D/calcium supplementation: ACTG A5280. First author: M.T. Yin. Journal: AIDS. Year of publication: 2017.

[5] Title: Chitosan-coated nano-liposomes for the oral delivery of berberine hydrochloride. First author: T. X. Nguyen. Journal: Journal of Materials Chemistry B. Year of publication: 2014.

[6] Title: Absorption kinetics of berberine and dihydroberberine and their impact on glycemia: A randomized, controlled, crossover pilot trial. First author: J. M. Moon. Journal: Nutrients. Year of publication: 2021.

[7] Title: Berberine phospholipid exerts a positive effect on the glycemic profile of overweight subjects with impaired fasting blood glucose (IFG): a randomized double-blind placebo-controlled clinical trial. First author: M. Rondanelli. Journal: European Review for Medical and Pharmacological Sciences. Year of publication: 2023

[8] Title: A 30-Day Randomized Crossover Human Study on the Safety and Tolerability of a New Micellar Berberine Formulation with Improved Bioavailability. First author: A. Ibi. Journal: Metabolites. Year of publication: 2025.

 

Back to blog

Leave a comment

Please note, comments need to be approved before they are published.